Tokuhara; Hidekazu
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tokuhara; Hidekazu.The latest application filed is for "heterocyclic compound".
Company Profile
6.25.27
- Tokuhara; Hidekazu - Kanagawa JP
- Tokuhara; Hidekazu - Fujisawa-shi JP
- Tokuhara; Hidekazu - Fujisawa JP
- TOKUHARA; Hidekazu - Osaka JP
- Tokuhara; Hidekazu - Osaka-shi JP
Patent Activity
| Patent | Date |
|---|---|
| Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function Grant 11,407,748 - Nakamura , et al. August 9, 2 | 2022-08-09 |
| Heterocyclic compound Grant 11,274,101 - Kamata , et al. March 15, 2 | 2022-03-15 |
| Heterocyclic Compound App 20220048916 - Hirayama; Takaharu ; et al. | 2022-02-17 |
| Heterocyclic compound Grant 11,242,348 - Kamata , et al. February 8, 2 | 2022-02-08 |
| Heterocyclic compound Grant 11,230,545 - Hirayama , et al. January 25, 2 | 2022-01-25 |
| Heterocyclic Compound App 20210363130 - ONO; Koji ; et al. | 2021-11-25 |
| Heterocyclic Compound App 20210332045 - Hirayama; Takaharu ; et al. | 2021-10-28 |
| Amide Compound App 20210277030 - Yamamoto; Satoshi ; et al. | 2021-09-09 |
| Heterocyclic amide compounds having RORyT inhibitory action Grant 11,053,262 - Yamamoto , et al. July 6, 2 | 2021-07-06 |
| Heterocyclic Compound App 20200270243 - NAKAMURA; Shinji ; et al. | 2020-08-27 |
| Heterocyclic Compound App 20200255439 - Kind Code | 2020-08-13 |
| Heterocyclic compound Grant 10,610,520 - Ikeda , et al. | 2020-04-07 |
| Amide Compound App 20200010487 - Yamamoto; Satoshi ; et al. | 2020-01-09 |
| Amide compound Grant 10,472,376 - Yamamoto , et al. Nov | 2019-11-12 |
| Heterocyclic compound Grant 10,323,026 - Ikeda , et al. | 2019-06-18 |
| Heterocyclic Compound App 20190125728 - IKEDA; Shuhei ; et al. | 2019-05-02 |
| Heterocyclic Compound App 20180319812 - Yamamoto; Satoshi ; et al. | 2018-11-08 |
| Heterocyclic compound Grant 10,106,556 - Ikeda , et al. October 23, 2 | 2018-10-23 |
| Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors Grant 10,093,629 - Yamamoto , et al. October 9, 2 | 2018-10-09 |
| Heterocyclic compound Grant 10,053,468 - Yamamoto , et al. August 21, 2 | 2018-08-21 |
| Heterocyclic Compound App 20180079756 - IKEDA; Shuhei ; et al. | 2018-03-22 |
| Heterocyclic Compound App 20170283406 - Ikeda; Shuhei ; et al. | 2017-10-05 |
| Heterocyclic Compounds And Their Use As Retinoid-related Orphan Receptor (ror) Gamma-t Inhibitors App 20170144973 - YAMAMOTO; Satoshi ; et al. | 2017-05-25 |
| Heterocyclic compound Grant 9,650,343 - Yamamoto , et al. May 16, 2 | 2017-05-16 |
| Heterocyclic compound Grant 9,630,924 - Yamamoto , et al. April 25, 2 | 2017-04-25 |
| Amide Compound App 20170107240 - Yamamoto; Satoshi ; et al. | 2017-04-20 |
| 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors Grant 9,624,170 - Koike , et al. April 18, 2 | 2017-04-18 |
| Heterocyclic Compound App 20170050974 - Yamamoto; Satoshi ; et al. | 2017-02-23 |
| Heterocyclic compound Grant 9,573,903 - Yamamoto , et al. February 21, 2 | 2017-02-21 |
| 4-(piperrazin-1-yl)-pyrrolidin-2-one Compounds As Monoacylglycerol Lipase (magl) Inhibitors App 20160318864 - KOIKE; Tatsuki ; et al. | 2016-11-03 |
| Heterocyclic Compound App 20160176822 - YAMAMOTO; Satoshi ; et al. | 2016-06-23 |
| Heterocyclic Compound App 20160176873 - YAMAMOTO; Satoshi ; et al. | 2016-06-23 |
| Heterocyclic Compound App 20160176872 - YAMAMOTO; Satoshi ; et al. | 2016-06-23 |
| Heterocyclic compound Grant 9,365,520 - Yamamoto , et al. June 14, 2 | 2016-06-14 |
| Heterocyclic Compound And Use Thereof App 20160046601 - KUROITA; Takanobu ; et al. | 2016-02-18 |
| Heterocyclic Compound App 20160002169 - YAMAMOTO; Satoshi ; et al. | 2016-01-07 |
| Heterocyclic compound and use thereof Grant 9,221,836 - Kuroita , et al. December 29, 2 | 2015-12-29 |
| Heterocyclic Compound And Use Thereof App 20150191486 - KUROITA; Takanobu ; et al. | 2015-07-09 |
| Heterocyclic compound and use thereof Grant 9,045,436 - Kuroita , et al. June 2, 2 | 2015-06-02 |
| Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors Grant 9,023,858 - Matsunaga , et al. May 5, 2 | 2015-05-05 |
| Heterocyclic compound and use thereof Grant 8,664,380 - Kuroita , et al. March 4, 2 | 2014-03-04 |
| Heterocyclic compound and use thereof Grant 8,466,282 - Kuroita , et al. June 18, 2 | 2013-06-18 |
| Fused Heterocyclic Compound And Application Thereof App 20130131050 - Matsunaga; Nobuyuki ; et al. | 2013-05-23 |
| Heterocyclic Compound And Use Thereof App 20120264733 - KUROITA; Takanobu ; et al. | 2012-10-18 |
| Heterocyclic Compound And Use Thereof App 20110178057 - Kuroita; Takanobu ; et al. | 2011-07-21 |
| Substituted imidazole compound and use thereof App 20090227560 - Kuroita; Takanobu ; et al. | 2009-09-10 |
| Substituted imidazole compound and use thereof App 20090156612 - Kuroita; Takanobu ; et al. | 2009-06-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 